Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / March / The 60 Percent Diagnostic Gap in ME
Clinical care Research and Innovations Molecular Pathology Omics Microbiology and Immunology Screening and monitoring

The 60 Percent Diagnostic Gap in M/E

What earlier mNGS testing could mean for labs and clinicians

By Jessica Allerton 03/12/2026 Discussion 4 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
  • Top Thought Leaders

Share

The 60 Percent Diagnostic Gap in M/E

Overview

Revise to specify the types of tests reduced by mNGS and the implications of the diagnostic gap.

Background

Meningitis and encephalitis are complex conditions that present with nonspecific symptoms, making rapid diagnosis challenging. Current diagnostic methods are often limited and hypothesis-driven, leading to a high rate of undiagnosed cases. The integration of mNGS could potentially streamline the diagnostic process and improve patient outcomes.

Data Highlights

In a modeled analysis, earlier use of mNGS reduced microbiologic testing by over 60% in infectious cases and by more than 90% in autoimmune encephalitis cases. Time to diagnosis was shortened by approximately 7 days for infectious cases and 10 days for autoimmune cases.

Key Findings

  • Over 60% of M/E cases remain undiagnosed after comprehensive evaluation.
  • Earlier mNGS testing can reduce the number of microbiologic tests ordered per patient.
  • Time to diagnosis can be shortened by 7 days for infectious M/E and 10 days for autoimmune encephalitis.
  • mNGS is particularly beneficial in immunocompromised patients and cases with atypical presentations.
  • Strict pre-analytic handling is crucial for accurate mNGS results.

Clinical Implications

Clinicians should consider integrating mNGS earlier in the diagnostic process for patients with M/E, especially in cases with limited CSF volume or when initial tests are inconclusive. This approach may lead to faster diagnoses and more appropriate management strategies.

Conclusion

The implementation of mNGS in the early diagnostic workup of M/E has the potential to significantly improve diagnostic accuracy and reduce time to treatment, addressing a critical gap in current clinical practice.

References

  1. Nature Medicine, 2024 -- Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections
  2. Open Forum Infectious Diseases, 2025 -- Metagenomic Next-generation Sequencing in Patients With Infectious Meningoencephalitis: A Comprehensive Systematic Literature Review and Meta-analysis
  3. Clinical Infectious Diseases, 2023 -- Evaluation of Meningitis/Encephalitis Diagnostic Gaps
  4. The ASCO Post — Racial, Ethnic Disparities in Diagnostic Procedures Following Abnormal Mammograms
  5. conexiant — AI Falls Short on Differential Dx
  6. the asco post — Racial, Ethnic Disparities in Diagnostic Procedures Following Abnormal Mammograms
  7. Surgical Endoscopy — Evaluation of Minimally Invasive Esophagectomy Through Expert and Crowd-Sourced Video Analysis
  8. AI Falls Short on Differential Dx
  9. Racial, Ethnic Disparities in Diagnostic Procedures Following Abnormal Mammograms
  10. https://academic.oup.com/cid/article/77/5/e14/7229814
  11. Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections | Nature Medicine
  12. Metagenomic Next-generation Sequencing in Patients With Infectious Meningoencephalitis: A Comprehensive Systematic Literature Review and Meta-analysis - PubMed
  13. Cerebrospinal Fluid Metagenomic Next-Generation Sequencing in Pediatric Central Nervous System Infection: Clinical Experience and Diagnostic Stewardship Strategies - PMC

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Research and Innovations
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Research Roundup
Research and Innovations
Research Roundup

January 31, 2024

1 min read

From spatial transcriptomics to AI diagnosis, we bring you the latest news in pathology and laboratory medicine

Flexible Solutions With FlexVUE
Research and Innovations
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

Defining the Next Generation of NGS
Research and Innovations
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.